Fosinopril sodium is a phosphinate-containing angiotensin-converting enzyme (ACE) inhibitor widely utilized in the clinical management of hypertension and heart failure. By blocking the conversion of angiotensin… Read more
















phosphinyl]acetic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F123599-82-6-rel-2-R-1S-2-Methyl-1-1-oxopropoxypropoxy4-phenylbutylphosphinylacetic-Acid.png&w=3840&q=75)
Fosinopril sodium is a phosphinate-containing angiotensin-converting enzyme (ACE) inhibitor widely utilized in the clinical management of hypertension and heart failure. By blocking the conversion of angiotensin I to angiotensin II, this agent effectively lowers systemic blood pressure and reduces vascular resistance. To ensure the safety and efficacy of the active pharmaceutical ingredient, laboratories require precise reference materials for rigorous analytical testing. This category contains a comprehensive range of Fosinopril sodium reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for accurate impurity profiling, method validation, and routine quality control during pharmaceutical manufacturing. Analytical chemists rely on these high-quality standards to identify, quantify, and monitor trace components, ensuring final products meet established regulatory specifications and consistency requirements throughout the production lifecycle.